E Fund Management’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
2024
Q4
$561K Sell
2024
Q3
$1.24M Sell
2024
Q2
$1.17M Buy
2024
Q1
$253K Buy
2023
Q3
Sell
2023
Q2
$244K Sell
2023
Q1
$451K Buy
2022
Q4
$226K Buy
2022
Q3
$380K Sell
2022
Q2
$548K Buy
2022
Q1
$310K Buy
2021
Q4
$206K Buy